tirzepatide/ niacinamide injection We are pleased to announce that we are expanding our Weight Management and Longevity offerings. Consider the Tirzepatide / in 4mL, a GIP and GLP-1 Receptor Agonist, for a variety Tirzepatide / Niacinamide - JUVVA

Iron deficiency, in particular, is strongly associated with hair loss and is more common in individuals with restricted caloric intake

Compounded drugs are not FDA-approved and dont have to undergo any safety, effectiveness, or manufacturing reviews

Starting in July 2026, eligible Medicare beneficiaries will gain access to certain weight-loss medications for $50 a month through a temporary initiative called the Medicare GLP-1 Bridge program

Access to Savings Programs: We help patients explore manufacturer savings programs and patient assistance options, which can significantly reduce the cost of Tirzepatide for eligible individuals

Compounded Medication Notice: Certain medications available through the FormBlends platform are compounded medications prepared by licensed 503A compounding pharmacies

If complications arise between scheduled appointments, you should be able to contact the clinic for guidance